Kezar Life Sciences, Inc. (KZR) Non-Current Deffered Revenue (2017 - 2018)

Kezar Life Sciences has reported Non-Current Deffered Revenue for 2 years, with the latest figure at $2.5 million in Q4 2018.

• Quarterly Non-Current Deffered Revenue rose 415.79% year-over-year to $2.5 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $2.5 million (up 415.79% YoY) and the FY2018 annual result came in at $2.5 million, up 415.79% from the prior year.
• Non-Current Deffered Revenue declined to $2.5 million in Q4 2018 per KZR's latest filing, from $2.6 million in the prior quarter.
• Over five years, Non-Current Deffered Revenue peaked at $2.7 million in Q2 2018 and troughed at $494000.0 in Q4 2017.